产品中心

产品货号

产品名称

规格

销售价

会员价

货期

产地

订购

CB28

Recombinant Human GALK2/GK2

10ug

1200

1080

现货

国产

CB28

Recombinant Human GALK2/GK2

50ug

3520

3168

现货

国产

CB28

Recombinant Human GALK2/GK2

500ug

13440

12096

现货

国产

CB28

Recombinant Human GALK2/GK2

1mg

19200

17280

现货

国产

  • 产品简介
  • 使用说明
  • 相关产品
  • 参考文献
  • 购买咨询
  • Catalog# CB28
    Source HEK293
    Description Recombinant Human N-acetylgalactosamine kinase/GALK2/GK2 is produced by our mammalian expression system in human cells. The target protein is expressed with sequence (Met1-Ala458) of Human GALK2 fused with a polyhistidine tag at the C-terminus.
    Names N-acetylgalactosamine kinase, also known as GalNAc kinase, Galactokinase 2, GALK2 and GK2, is a member of the GHMP kinase family and GalK subfamily.
    Accession # Q01415
    Formulation Supplied as a 0.2 μm filtered solution of 20mM PB,150mM NaCl,pH7.4
    Shipping The product is shipped on dry ice/ice packs.
    Storage Store at < -20°C, stable for 6 months after receipt.
    Please minimize freeze-thaw cycles.
    Purity Greater than 95% as determined by RP-HPLC and reducing SDS-PAGE.
    Endotoxin Less than 0.1 ng/µg (1 IEU/µg).
    Amino Acid Sequence
    MATESPATRRVQVAEHPRLLKLKEMFNSKFGSIPKFYVRAPGRVNIIGEHIDYCGYSVLPMAVEQ DVLIAVEPVKTYALQLANTNPLYPDFSTSANNIQIDKTKPLWHNYFLCGLKGIQEHFGLSNLTGM NCLVDGNIPPSSGLSSSSALVCCAGLVTLTVLGRNLSKVELAEICAKSERYIGTEGGGMDQSISF LAEEGTAKLIEFSPLRATDVKLPSGAVFVIANSCVEMNKAATSHFNIRVMECRLAAKLLAKYKSL QWDKVLRLEEVQAKLGISLEEMLLVTEDALHPEPYNPEEICRCLGISLEELRTQILSPNTQDVLI FKLYQRAKHVYSEAARVLQFKKICEEAPENMVQLLGELMNQSHMSCRDMYECSCPELDQLVDICR KFGAQGSRLTGAGWGGCTVSMVPADKLPSFLANVHKAYYQRSDGSLAPEKQSLFATKPGGGALVL LEAVDHHHHHH
    Background GALK2 acts as a galactokinase when galactose is present at high concentrations. GALK2 may be involved in a salvage pathway for the reutilization of free GalNAc derived from the degradation of complex carbohydrates. GALK2 has been reported to participate in pathways , such as Amino sugar and nucleotide sugar metabolism, Galactose metabolism and Metabolic pathways.